46 under or overprescription cause the inappropriate treatment of the disease. 3% ( n=104 ) received treatment containing ics. 6% in stage iii , and 16. in stage ii overtreatment ( 91. guideline concordant treatment rate was as high as 84. the most administered treatment regimen was laba ics lama combination ( 43. 5% ) patients on short acting bronchodilators used as rescue drugs in addition to maintenance therapy.